Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leese

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Diabetes|May 22, 2007
5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy menDaniel J Cuthbertson, John A Babraj, Kirsteen J W Mustard, et al.
Journal of Medicinal Chemistry|December 12, 2017
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal StructureWolfgang Dohle, Fabrice L Jourdan, Grégory Menchon, et al.
Diabetologia|August 16, 2012
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in ScotlandC A Jackson, N R V Jones, J J Walker, et al.
Diabetologia|January 12, 2019
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational studyStuart J McGurnaghan, Liam Brierley, Thomas M Caparrotta, et al.
Chemical Communications (Cambridge, England)|April 14, 2010
Chimeric microtubule disruptorsMathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Diabetologia|June 13, 2012
Diabetic retinopathy at diagnosis of type 2 diabetes in ScotlandH C Looker, S O Nyangoma, D Cromie, et al.
The British Journal of Ophthalmology|March 7, 2014
Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening ProgrammeH C Looker, S O Nyangoma, D T Cromie, et al.
Journal of Medicinal Chemistry|February 12, 2008
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agentsMathew P Leese, Fabrice L Jourdan, Keira Gaukroger, et al.
Diabetologia|February 20, 2021
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetesAndreas Höhn, Anita Jeyam, Thomas M Caparrotta, et al.
International Journal of Clinical Practice|March 21, 2013
The Tayside insulin management course: an effective education programme in type 1 diabetesL V M Jordan, M Robertson, L Grant, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Diabetes|May 22, 2007
5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy menDaniel J Cuthbertson, John A Babraj, Kirsteen J W Mustard, et al.
Journal of Medicinal Chemistry|December 12, 2017
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal StructureWolfgang Dohle, Fabrice L Jourdan, Grégory Menchon, et al.
Diabetologia|August 16, 2012
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in ScotlandC A Jackson, N R V Jones, J J Walker, et al.
Diabetologia|January 12, 2019
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational studyStuart J McGurnaghan, Liam Brierley, Thomas M Caparrotta, et al.
Chemical Communications (Cambridge, England)|April 14, 2010
Chimeric microtubule disruptorsMathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Diabetologia|June 13, 2012
Diabetic retinopathy at diagnosis of type 2 diabetes in ScotlandH C Looker, S O Nyangoma, D Cromie, et al.
The British Journal of Ophthalmology|March 7, 2014
Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening ProgrammeH C Looker, S O Nyangoma, D T Cromie, et al.
Journal of Medicinal Chemistry|February 12, 2008
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agentsMathew P Leese, Fabrice L Jourdan, Keira Gaukroger, et al.
Diabetologia|February 20, 2021
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetesAndreas Höhn, Anita Jeyam, Thomas M Caparrotta, et al.
International Journal of Clinical Practice|March 21, 2013
The Tayside insulin management course: an effective education programme in type 1 diabetesL V M Jordan, M Robertson, L Grant, et al.
Pageof 21